Acadia Pharmaceuticals | ACAD - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
ALKERMES USD 331.33M 7M 2026-03
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Biogen USD 1.82B 169.5M 2026-03
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Cytokinetics USD 19.2M 1.44M 2026-03
Eisai JPY 153.41B 15.44B 2026-03
Eli Lilly USD 15.92B 1.33B 2025-12
Incyte USD 1.17B 217.51M 2026-03
J&J USD 17.24B 642M 2026-03
Moderna USD -566M 792M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Prothena USD 21K 2.39M 2025-12
PTC Therapeutics USD 232.94M 84.56M 2026-03
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
Ultragenyx Pharmaceutical USD 106M 72M 2026-03
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03